Eli Lilly and Company (LLY) Total Assets by Year
Eli Lilly and Company closed fiscal year 2025 with $112.5B in total assets, $85.9B in total liabilities and $26.5B in shareholder equity. This represents an increase of 42.9% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Eli Lilly and Company has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
LLY Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $112.5B+42.9% | $78.7B+23.0% | $64.0B+29.3% | $49.5B+1.4% | $48.8B+4.7% | $46.6B+18.7% | $39.3B-10.5% | $43.9B-2.4% | $45.0B+15.9% | $38.8B+9.1% | $35.6B-2.0% | $36.3B+3.0% | $35.2B+2.5% | $34.4B+2.2% | $33.7B |
| Total Liabilities | $85.9B+33.4% | $64.4B+21.1% | $53.2B+37.1% | $38.8B-2.5% | $39.8B-2.8% | $41.0B+11.8% | $36.7B+7.6% | $34.1B+2.1% | $33.4B+34.6% | $24.8B+18.1% | $21.0B+0.3% | $20.9B+18.8% | $17.6B-10.3% | $19.6B-2.4% | $20.1B |
| Total Equity | $26.5B+85.9% | $14.3B+32.5% | $10.8B+1.1% | $10.6B+18.6% | $9.0B+59.2% | $5.6B+116.4% | $2.6B-73.5% | $9.8B-15.2% | $11.6B-17.2% | $14.0B-3.9% | $14.6B-5.2% | $15.4B-12.8% | $17.6B+19.4% | $14.8B+9.0% | $13.5B |
LLY Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $142.3B+41.0% | $116.6B+30.4% | $112.5B+42.9% | $114.9B+52.0% | $100.9B+40.4% | $89.4B+39.8% | $78.7B+23.0% | $75.6B+30.5% | $71.9B+31.1% | $63.9B+20.3% | $64.0B+29.3% | $57.9B+22.0% |
| Total Liabilities | $108.4B+31.2% | $85.4B+16.0% | $85.9B+33.4% | $91.1B+48.5% | $82.6B+41.7% | $73.6B+44.0% | $64.4B+21.1% | $61.4B+31.4% | $58.3B+33.3% | $51.1B+21.8% | $53.2B+37.1% | $46.7B+24.9% |
| Total Equity | $33.9B+85.4% | $31.2B+97.9% | $26.5B+85.9% | $23.8B+67.1% | $18.3B+34.7% | $15.8B+23.0% | $14.3B+32.5% | $14.2B+26.9% | $13.6B+22.6% | $12.8B+14.5% | $10.8B+1.1% | $11.2B+11.4% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Eli Lilly and Company financials
Frequently Asked Questions
What was Eli Lilly and Company's total assets in fiscal year 2025?
Eli Lilly and Company closed fiscal year 2025 with $112.5B in total assets, $85.9B in total liabilities and $26.5B in shareholder equity.
How fast is Eli Lilly and Company's total assets growing?
Eli Lilly and Company (LLY) total assets rose by 42.9% year over year, from $78.7B to $112.5B in fiscal year 2025.
How has Eli Lilly and Company's total assets changed over the years?
Across the 15 fiscal years this page covers, Eli Lilly and Company (LLY) total assets went from $33.7B in fiscal year 2011 to $112.5B in fiscal year 2025.
What was Eli Lilly and Company's total assets in the most recent quarter?
Eli Lilly and Company (LLY) reported $142.3B in total assets in Q2 2026. This represents an increase of 41.0% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Eli Lilly and Company (LLY) reported on that line in every period on record.